Inventor
MAHMOUD MIRMEHRABI
Inventor
CA
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07BGeneral methods of organic chemistry25%
C07CAcyclic or carbocyclic compounds17%
C07DHeterocyclic compounds8%
PatentTitleYear
11,938,101Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide202411,304,914Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide202211,254,652Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to PTC THERAPEUTICS INC (2)· patent assignee history
2022Patents assigned to AGIOS PHARMACEUTICALS INC (1)· patent assignee history
2022–2024Based in CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PTC THERAPEUTICS INC | 2 | 2022–2024 |
| AGIOS PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CA | 3 | 2022–2024 |